Cargando…
Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure
The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies an...
Autores principales: | Boué, Stéphanie, Exner, Thomas, Ghosh, Samik, Belcastro, Vincenzo, Dokler, Joh, Page, David, Boda, Akash, Bonjour, Filipe, Hardy, Barry, Vanscheeuwijck, Patrick, Hoeng, Julia, Peitsch, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657032/ https://www.ncbi.nlm.nih.gov/pubmed/29123642 http://dx.doi.org/10.12688/f1000research.10493.2 |
Ejemplares similares
-
GladiaTOX: GLobal Assessment of Dose-IndicAtor in TOXicology
por: Belcastro, Vincenzo, et al.
Publicado: (2019) -
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products
por: Hoeng, Julia, et al.
Publicado: (2019) -
Embracing Transparency Through Data Sharing
por: Boué, Stéphanie, et al.
Publicado: (2018) -
An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes
por: Phillips, Blaine, et al.
Publicado: (2016) -
An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe(−/−) Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes
por: Phillips, Blaine, et al.
Publicado: (2016)